Dear Molecular Imaging Insider,
Once again, this year's annual RSNA meeting provided a wealth of fascinating and groundbreaking scientific research on a number of fronts, not the least of which was the additional exploration of PET/MRI.
Researchers from Essen University Hospital in Germany found good agreement between PET and MR images in patients with acute myocardial infarction. The findings support the possibility of using PET/MRI to improve risk stratification in this patient population. Read more in this newsletter's Insider Exclusive.
In other PET/MRI news, a group from NYU Langone Medical Center found that simultaneous PET/MRI can produce diagnostic-quality brain scans and interpretation results that compare favorably with PET/CT in patients with suspected dementia. The study showed a high degree of intrareader agreement for overall diagnosis and identification of regional brain abnormalities, prompting the researchers to conclude that simultaneous PET/MRI is a viable clinical tool for evaluating patients with dementia.
Evidence is also mounting for the efficacy of whole-body FDG-PET/MRI for staging women with suspected pelvic malignancies. Another group of researchers from Essen University Hospital found that the hybrid modality correctly identified metastatic lesions and provided greater lesion conspicuity and diagnostic confidence than MRI alone.
Also at RSNA 2013, New York researchers reported that radioimmunotherapy could offer a strategy for curing HIV infection. The hope is that the new treatment could kill off the HIV-infected cells that remain after antiretroviral therapy.
Be sure to stay in touch with the Molecular Imaging Digital Community on a daily basis to learn about the latest news and research.
And, most of all, everyone at AuntMinnie.com wishes our readers a joyous holiday season and a very healthy and prosperous 2014.
